Decreased Neurotrophic Response to Birth Hypoxia in the Etiology of Schizophrenia

Biological Psychiatry

Volumn 64, Issue 9, 2008, Pages 797-802

  Cannon, Tyrone D ^a   Yolken, Robert ^b   Buka, Stephen ^c   Torrey, E Fuller ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d Stanley Medical Research Institute   (United States)

Author keywords

Brain derived neurotrophic factor; hypoxia; neuroprotection; schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; NEWBORN; NEWBORN HYPOXIA; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; UMBILICAL CORD BLOOD;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FETAL HYPOXIA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHIONINE; MIDDLE AGED; RISK FACTORS; SCHIZOPHRENIA; VALINE;

EID: 53249138261     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.04.012     Document Type: Article

References (49)

1. Buka S.L., Tsuang M.T., and Lipsitt L.P. Pregnancy/delivery complications and psychiatric diagnosis. A prospective study. Arch Gen Psychiatry 50 (1993) 151-156
2. Cannon T.D., Rosso I.M., Hollister J.M., Bearden C.E., Sanchez L.E., and Hadley T. A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. Schizophr Bull 26 (2000) 351-366
3. Rosso I.M., Cannon T.D., Huttunen T., Huttunen M.O., Lonnqvist J., and Gasperoni T.L. Obstetric risk factors for early-onset schizophrenia in a Finnish birth cohort. Am J Psychiatry 157 (2000) 801-807
4. Cannon M., Jones P.B., and Murray R.M. Obstetric complications and schizophrenia: Historical and meta-analytic review. Am J Psychiatry 159 (2002) 1080-1092
5. Cannon T.D., van Erp T.G., Bearden C.E., Loewy R., Thompson P., Toga A.W., et al. Early and late neurodevelopmental influences in the prodrome to schizophrenia: Contributions of genes, environment, and their interactions. Schizophr Bull 29 (2003) 653-669
6. Schmidt-Kastner R., van Os J., Steinbusch W.M.H., and Schmitz C. Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. Schizophr Res 84 (2006) 253-271
7. Cannon T.D., Mednick S.A., and Parnas J. Genetic and perinatal determinants of structural brain deficits in schizophrenia. Arch Gen Psychiatry 46 (1989) 883-889
8. Cannon T.D., Mednick S.A., Parnas J., Schulsinger F., Praestholm J., and Vestergaard A. Developmental brain abnormalities in the offspring of schizophrenic mothers. I. Contributions of genetic and perinatal factors. Arch Gen Psychiatry 50 (1993) 551-564
9. Cannon T.D., van Erp T.G., Rosso I.M., Huttunen M., Lonnqvist J., Pirkola T., et al. Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 59 (2002) 35-41
10. van Erp T.G., Saleh P.A., Huttunen M., Lonnqvist J., Kaprio J., Salonen O., et al. Hippocampal volumes in schizophrenic twins. Arch Gen Psychiatry 61 (2004) 346-353
11. Van Erp T.G., Saleh P.A., Rosso I.M., Huttunen M., Lonnqvist J., Pirkola T., et al. Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry 159 (2002) 1514-1520
12. Gilmore J.H., Jarskog L.F., and Vadlamudi S. Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat. J Neuroimmunol 138 (2003) 49-55
13. Gilmore J.H., Jarskog L.F., and Vadlamudi S. Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat. J Neuroimmunol 159 (2005) 106-112
14. Marx C.E., Vance B.J., Jarskog L.F., Chescheir N.C., and Gilmore J.H. Nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 levels in human amniotic fluid. Am J Obstet Gynecol 181 (1999) 1225-1230
15. Rocamora N., Massieu L., Boddeke H.W., Palacios J.M., and Mengod G. Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNAs in adult rat brain after intrahippocampal injection of quinolinic acid. Brain Res Mol Brain Res 26 (1994) 89-98
16. Shoval G., and Weizman A. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol 15 (2005) 319-329
17. Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., and Kleinman J.E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8 (2003) 592-610
18. Lee H.T., Chang Y.C., Wang L.Y., Wang S.T., Huang C.C., and Ho C.J. cAMP response element-binding protein activation in ligation preconditioning in neonatal brain. Ann Neurol 56 (2004) 611-623
19. Meng M., Zhiling W., Hui Z., Shengfu L., Dan Y., and Jiping H. Cellular levels of TrkB and MAPK in the neuroprotective role of BDNF for embryonic rat cortical neurons against hypoxia in vitro. Int J Dev Neurosci 23 (2005) 515-521
20. Nyakas C., Buwalda B., and Luiten P.G. Hypoxia and brain development. Prog Neurobiol 49 (1996) 1-51
21. Rees S., Mallard C., Breen S., Stringer M., Cock M., and Harding R. Fetal brain injury following prolonged hypoxemia and placental insufficiency: A review. Comp Biochem Physiol A Mol Integr Physiol 119 (1998) 653-660
22. Glantz L.A., and Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57 (2000) 65-73
23. Selemon L.D., and Goldman-Rakic P.S. The reduced neuropil hypothesis: A circuit based model of schizophrenia. Biol Psychiatry 45 (1999) 17-25
24. Selemon L.D., Rajkowska G., and Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 52 (1995) 805-818 discussion 819-820
25. Weickert C.S., Ligons D.L., Romanczyk T., Ungaro G., Hyde T.M., Herman M.M., et al. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry 10 (2005) 637-650
26. Ampuero E., Dagnino-Subiabre A., Sandoval R., Zepeda-Carreno R., Sandoval S., Viedma A., et al. Status epilepticus induces region-specific changes in dendritic spines, dendritic length and TrkB protein content of rat brain cortex. Brain Res 1150 (2007) 225-238
27. Niswader K.R., and Gordon M. The Collaborative Perinatal Study of the National Institute of Neurological Diseases and Stroke: The Women and Their Pregnancies (1972), W.B. Saunders, Philadelphia
28. Cannon T.D. On the nature and mechanisms of obstetric influences in schizophrenia: A review and synthesis. Int Rev Psychiatry 9 (1997) 387-397
29. Nawa H., Carnahan J., and Gall C. BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: Partial disagreement with mRNA levels. Eur J Neurosci 7 (1995) 1527-1535
30. Miyazaki K., Narita N., Sakuta R., Miyahara T., Naruse H., Okado N., and Narita M. Serum neurotrophin concentrations in autism and mental retardation: A pilot study. Brain Dev 26 (2004) 292-295
31. Geller B., Badner J.A., Tillman R., Christian S.L., Bolhofner K., and Cook Jr. E.H. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 161 (2004) 1698-1700
32. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
33. Brown H., and Prescott R. Applied Mixed Models in Medicine (1999), John Wiley & Sons, New York
34. Bain M., Juszczak E., McInneny K., and Kendell R.E. Obstetric complications and affective psychoses. Two case-control studies based on structured obstetric records. Br J Psychiatry 176 (2000) 523-526
35. Surtees P.G., Wainwright N.W., Willis-Owen S.A., Sandhu M.S., Luben R., Day N.E., and Flint J. The brain-derived neurotrophic factor Val66Met polymorphism is associated with sense of coherence in a non-clinical community sample of 7335 adults. J Psychiatr Res 41 (2007) 707-710
36. Nakahashi T., Fujimura H., Altar C.A., Li J., Kambayashi J., Tandon N.N., and Sun B. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 470 (2000) 113-117
37. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation?. J Exp Med 189 (1999) 865-870
38. Toyooka K., Asama K., Watanabe Y., Muratake T., Takahashi M., Someya T., and Nawa H. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 110 (2002) 249-257
39. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., and Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36 (2004) 131-137
40. Cannon T.D., Hennah W., van Erp T.G., Thompson P.M., Lonnqvist J., Huttunen M., et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry 62 (2005) 1205-1213
41. Shinoda T., Taya S., Tsuboi D., Hikita T., Matsuzawa R., Kuroda S., et al. DISC1 regulates neurotrophin-induced axon elongation via interaction with Grb2. J Neurosci 27 (2007) 4-14
42. Corfas G., Roy K., and Buxbaum J.D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 7 (2004) 575-580
43. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71 (2002) 877-892
44. Gu Z., Jiang Q., Fu A.K., Ip N.Y., and Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 25 (2005) 4974-4984
45. Malamitsi-Puchner A., Economou E., Rigopoulou O., and Boutsikou T. Perinatal changes of brain-derived neurotrophic factor in pre- and fullterm neonates. Early Hum Dev 76 (2004) 17-22
46. Weinstock-Guttman B., Zivadinov R., Tamano-Blanco M., Abdelrahman N., Badgett D., Durfee J., et al. Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis. J Neuroimmunol 188 (2007) 167-174
47. McGlashan T.H., and Hoffman R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 57 (2000) 637-648
48. Ellman L.M., Huttunen M., Lonnqvist J., and Cannon T.D. The effects of genetic liability for schizophrenia and maternal smoking during pregnancy on obstetric complications. Schizophr Res 93 (2007) 229-236
49. Stroud L.R., Solomon C., Shenassa E., Papandonatos G., Niaura R., Lipsitt L.P., et al. Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: Still valid after all these years. Psychoneuroendocrinology 32 (2007) 140-150